Torrent Pharmaceuticals is currently trading at Rs. 1666.75, up by 14.50 points or 0.88% from its previous closing of Rs. 1652.25 on the BSE.
The scrip opened at Rs. 1640.05 and has touched a high and low of Rs. 1687.00 and Rs. 1640.05 respectively. So far 3841 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 1722.70 on 09-Nov-2022 and a 52 week low of Rs. 1242.50 on 12-May-2022.
Last one week high and low of the scrip stood at Rs. 1722.70 and Rs. 1644.45 respectively. The current market cap of the company is Rs. 56283.48 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 20.87% and 7.88% respectively.
Torrent Pharmaceuticals has raised Rs 500 crore through issuance of Non-Convertible Debentures (NCDs) on Private Placement basis on November 09, 2022. The date of maturity of said NCDs will be 7 years from date of allotment.
Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.